Committee on Publication Ethics launches ethical guidelines for peer reviewers
Scholarly journals need to ensure that their peer reviewers act constructively, respect confidentiality and avoid conflicts of interests, according to new guidelines launched by the Committee on Publication Ethics (COPE)
Other
Mar 25, 2013 |
not rated yet |
0
New guidance urges improved reporting of important outcomes for patients in trials publications
Clinical trials provide us with the best evidence to guide patient treatment and inform health policy. Yet, crucial information, on outcomes reported directly by patients such as their quality of life, is often left out of ...
Other
Feb 28, 2013 |
not rated yet |
0
Drug delivery strategy eliminates myotonia symptoms in mice with myotonic dystrophy
By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms ...
Diseases, Conditions, Syndromes
Feb 22, 2013 |
5 / 5 (1) |
0
Greater transparency needed in publishing information from clinical trials
An initiative from the drugs regulator, the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, which has been greeted with cautious ...
Other
Jan 29, 2013 |
not rated yet |
0
New publication guidelines for systematic reviews from BMC Medicine
Two articles in BioMed Central's open access journal BMC Medicine by Geoff Wong, Trisha Greenhalgh and colleagues, propose publication guidelines for both realist synthesis and meta-narrative reviews.
Other
Jan 28, 2013 |
not rated yet |
0
Spin and bias in published studies of breast cancer trials
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to new research published in the cancer journal Annals of ...
Cancer
Jan 09, 2013 |
not rated yet |
0
|
Targeted gene silencing drugs are more than 500 times more effective with new delivery method
Small interfering RNAs (siRNAs) are a potent new drug class that can silence a disease-causing gene, but delivering them to a target cell can be challenging. An innovative delivery approach that dramatically ...
Medical research
Dec 21, 2012 |
5 / 5 (2) |
0
PLOS Medicine editors comment on progress of World Health Report 2012
In this month's editorial, the PLOS Medicine Editors comment on the World Health Organization's (WHO) latest World Health Report, originally planned for publication in 2012, and the outcomes of the journal's collaboration with W ...
Health
Sep 25, 2012 |
not rated yet |
0
Better air quality indicators are needed for the world's cities
In their August editorial, the PLOS Medicine Editors reflect on a recent Policy Forum article by Jason Corburn and Alison Cohen, which describes the need for urban health equity indicators to guide public health policy in cit ...
Health
Aug 28, 2012 |
not rated yet |
0
Accidents don't just happen: New Book on trends and takeaways in injury research
Two esteemed researchers in the field of injury research have published the most comprehensive reference book to date on the methods and approaches underpinning the scientific discipline of injury control and prevention.
Health
Jan 31, 2012 |
2 / 5 (1) |
0
We may be less happy, but our language isn't
"If it bleeds, it leads," goes the cynical saying with television and newspaper editors. In other words, most news is bad news and the worst news gets the big story on the front page.
Psychology & Psychiatry
Jan 12, 2012 |
4.1 / 5 (8) |
3
|
Living-long paper withdrawn after data questioned
The authors of a widely reported study that offered an early glimpse into factors leading to long life are withdrawing the paper because of problems with some of the data they used.
Genetics
Jul 21, 2011 |
not rated yet |
0
